One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2021-148497
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 9 |
Affiliation: Memorial Sloan Kettering Cancer Center, Mayo Clinic, Banner Health, The Ohio State University, Cornell University, Stony Brook University Hospital, Actinium Pharmaceuticals (United States), Yale University, The University of Texas MD Anderson Cancer Center, Roswell Park Cancer Institute, Fred Hutch Cancer Center, Princess Margaret Cancer Centre, University Health Network, Medical College of Wisconsin, University Hospitals Seidman Cancer Center, Ottawa Hospital, University of Ottawa, Loyola University Medical Center, Swedish Medical Center, University of Kansas Medical Center, University of Nebraska Medical Center, Baylor University Medical Center, Saint Louis Zoo, Washington University in St. Louis, University Hospitals of Cleveland, Texas Oncology, University of North Carolina at Chapel Hill
Clinical Experience in the Randomized Phase 3 Sierra Trial: Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Conditioning Enables Hematopoietic Cell Transplantation with Successful Engraftment and Acceptable Safety in Patients with Active, Relapsed/Refractory AML Not Responding to Targeted Therapies
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
